Website profile

The Manila Times

The Manila Times is a national daily newspaper in the Philippines that delivers trusted, quality content in print and digital editions.

  • 86,840articles · 365d
  • 3+ hour agolatest article
  • Sep 13, 2025earliest in window
  • 94%with images
  • 266avg words
articles per day
Categories
  • Economy, Business & Finance 46,507
  • Finance & Business 38,038
  • News 30,506
  • Business & Industrial 10,890
  • Politics 7,755
  • Finance 7,588
  • Science & Technology 5,936
  • Medical 5,570

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

The Manila Times
manilatimes.net > 01/12/2026 > tmt-newswire > globenewswire > recludix-pharma-announces-equity-financing-to-advance-clinical-development-of-novel-sh2-domain-inhibitors > 2257154

Recludix Pharma Announces Equity Financing to Advance Clinical Development of Novel SH2 Domain Inhibitors

8+ mon, 22+ hour ago   (167+ words) The Manila Times Recludix Pharma Announces Equity Financing to Advance Clinical Development of Novel SH2 Domain Inhibitors - Financing led by institutional investors, with participation from new investor Eli Lilly and Company - Inclusive of this investment, a total of $123 million in equity…...